Dr. Reddy's Laboratories LTD.

We are a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic focus areas are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance.. Dr. Reddy's is recognized as one of the largest API suppliers worldwide, catering to leading innovator and generic companies across China, the U.S., Europe, Latin America, Japan, Korea and other emerging markets. The launch of Dr. Reddy’s XCEED – a digital customer service platform - gives customers instant access to an industry-leading portfolio that spans across a wide range of indications and complex molecules such as steroids, peptides, or highly potent APIs (HPAPI). Customers across the globe can manage the whole business process in real-time, from ordering samples to submitting and tracking their orders, but also closely interacting with Dr. Reddy’s interdisciplinary support team and much more. “

China is a strategic market for Dr. Reddy’s, and we are proud of our long-term partnerships with China’s leading pharmaceutical companies. Our API business, which operates through our office in Shanghai, is a testament to our commitment to this market. With a local team of experts in Sales, Regulatory, and Customer Support, we are well-positioned to serve the needs of our Chinese partners. 

“For more information, log on to: www.api.drreddys.com